Trials / Enrolling By Invitation
Enrolling By InvitationNCT07081841
AB-1005 Long-Term Follow-up Study
Long-Term Safety and Efficacy Follow-up of AB-1005 Gene Transfer Study Participants With Parkinson's Disease or Multiple System Atrophy
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 132 (estimated)
- Sponsor
- AskBio Inc · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is an observational, long term, follow-up study for participants with Parkinson's disease (PD) or Multiple System Atrophy-Parkinsonian subtype (MSA-P) who participated in prior interventional studies with AB-1005. It is intended to better understand the long-term safety of AB-1005, how well tolerated it is and how long lasting the effects are.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation | This is an observational study in which safety laboratories and non-invasive routine clinical assessments are conducted to gauge long term safety and efficacy. |
Timeline
- Start date
- 2025-09-04
- Primary completion
- 2037-09-30
- Completion
- 2038-03-30
- First posted
- 2025-07-23
- Last updated
- 2025-10-02
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07081841. Inclusion in this directory is not an endorsement.